Umbilical Cord Tissue Allografts for Thoracolumbar Paraspinal Defects
Paraspinal muscle degeneration — fatty infiltration, enthesopathy, and ECM disruption — is increasingly recognized as an underlying contributor to chronic low back pain. This multi-site observational study, published in Biomedicines (2026, 14, 1030), evaluated cryopreserved human umbilical cord tissue (UCT) allografts in 117 patients with thoracic or lumbar paraspinal defects refractory to standard conservative care.
Study Overview
- Design: IRB-approved multi-site observational study (IRCM-2022-311)
- Participants: 117 patients across 11 clinics with MRI- or ultrasound-confirmed paraspinal degeneration refractory to ≥3 months of standard conservative care
- Intervention: Ultrasound-guided intramuscular application of 2 cc (150 mg) cryopreserved UCT allograft — single (n=40), double (n=57), or triple (n=20) application cohorts
- Outcomes: NPRS, WOMAC (Pain, Stiffness, Physical Function, Total), and QOLS at baseline through patient-specific endpoint
Results
Patient-reported improvement (baseline to endpoint):
- Single application: 27 of 40 patients (68%) reported WOMAC Total improvement
- Double application: 46 of 57 patients (81%) reported WOMAC Total improvement
- Triple application: 17 of 20 patients (85%) reported WOMAC Total improvement; 15 of 18 (83%) reported NPRS improvement
Mean change from baseline:
- NPRS: 6.54 → 4.65 (single), 4.41 → 3.17 (double), 4.75 → 2.00 (triple, −58%)
- WOMAC Total: 49.72 → 38.98 (single), 43.56 → 29.84 (double), 41.95 → 25.55 (triple, −39%)
- Within-group effect sizes on WOMAC Total were large across all cohorts and increased with application count (r = 0.61 single, 0.78 double, 0.87 triple)
Between-group post-hoc analysis (Bonferroni-adjusted) found multi-application cohorts achieved significantly greater endpoint improvement than the single-application cohort on NPRS, WOMAC Pain, Physical Function, and Total. Zero adverse events and zero complications were reported across the full 117-patient cohort.
As with any observational repository data, findings reflect patient-reported outcomes in a real-world clinical setting and should be interpreted in light of the study’s stated limitations — no control arm, non-standardized reapplication timing, and no follow-up imaging. The results do not establish causation.
Tissue Rationale
Paraspinal muscle ECM is composed primarily of type I collagen, with secondary contributions from types III, V, IX, and XI. UCT shares a comparable collagen profile (types I, II, III, IV, V, VI, XII, and XIV, with type I predominant) along with hyaluronic acid, glycosaminoglycans, and proteoglycans. Cryopreservation preserves the tissue’s original structural and biochemical attributes for homologous use as a structural matrix supplement at the site of degeneration.